Nataliya Reznichenko

17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial

Sean C. Blackwell, Cynthia Gyamfi‐Bannerman, Joseph Biggio et al. · American Journal of Perinatology · 2019 · 222 citations · Full text

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

Steven R. Feldman, Nataliya Reznichenko, Grażyna Pulka et al. · BioDrugs · 2021 · 30 citations · Full text

Randomized, double-blind, multicenter study to evaluate efficacy, safety, tolerability, and immunogenicity between AVT04 and the reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis

Steven R. Feldman, Nataliya Reznichenko, Fausto Berti et al. · Expert Opinion on Biological Therapy · 2023 · 22 citations · Full text

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

Kim Papp, Mark Lebwohl, Diamant Thaçi et al. · BioDrugs · 2023 · 21 citations · Full text

A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis

Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni et al. · Journal of the American Academy of Dermatology · 2024 · 17 citations · Full text